Journal of Clinical Endocrinology & Metabolism, Vol 70, 930-938, Copyright © 1990 by Endocrine Society

ARTICLES

The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure

M Parisien, SJ Silverberg, E Shane, L de la Cruz, R Lindsay, JP Bilezikian and DW Dempster
Regional Bone Center, Helen Hayes Hospital (New York State Department of Health), West Haverstraw 10993.

To evaluate the effects of primary hyperparathyroidism (PHPT) on bone mass and structure, we have studied the iliac crest biopsies of 27 patients, 10 males (28-68 yr old) and 17 females (26-72 yr old) with mild PHPT after in vivo tetracycline labeling. All patients had mild hypercalcemia in the absence of any other cause and elevated levels of PTH without radiological evidence of bone disease. Static parameters of bone turnover (osteoid surface, osteoid volume, and eroded surface) were elevated in both men and women compared to normal values; the midmolecule RIA for PTH (PTHMM) was positively correlated with osteoid surface (r = 0.44; P less than 0.025) and eroded surface (r = 0.58; P less than 0.005). Dynamic parameters of bone turnover (mineralizing surface, expressed as double plus half single labeled surface, and bone formation rate at tissue level) were elevated compared to normal values; PTHMM was positively correlated with double plus half single labeled surfaces (r = 0.33; P less than 0.05) and with bone formation rate at the tissue level (r = 0.37; P less than 0.05). The mineral apposition rate was within the limits of normal values and positively correlated with PTHMM (r = 0.34; P less than 0.05). Histomorphometric parameters of bone structure [cancellous bone volume (BV/TV), trabecular thickness (Tb. Th), trabecular number (Tb.N), trabecular separation (Tb.Sp), cortical thickness (Ct.Th), and total bone density (TBD)] were compared to those in 20 autopsy control subjects, 12 men (33-60 yr old) and 8 women (27-75 yr old). BV/TV and Tb.N were significantly higher in PHPT patients than controls (P less than 0.02 and P less than 0.001, respectively). Tb.Sp was significantly lower in PHPT patients than controls (P less than 0.001), whereas Tb.Th was not significantly different between PHPT patients and controls. Ct.Th was significantly lower in PHPT patients than in controls (P less than 0.001), whereas TBD was not significantly different between the two groups. BV/TV was negatively correlated with age in both controls and PHPT patients. Tb.N showed a negative correlation and Tb.Sp a positive correlation with age in controls (r = -0.47; P less than 0.05 and r = 0.52; P less than 0.02, respectively), but they were not significantly dependent on age in PHPT patients. Tb.Th, while showing no significant age-related change in controls, was negatively correlated with age in PHPT patients (r = -0.42; P less than 0.05).(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				P. Chavassieux, E. Seeman, and P. D. Delmas Insights into Material and Structural Basis of Bone Fragility from Diseases Associated with Fractures: How Determinants of the Biomechanical Properties of Bone Are Compromised by Disease Endocr. Rev., April 1, 2007; 28(2): 151 - 164. [Abstract] [Full Text] [PDF]

				T. L. Nickolas, D. J. McMahon, and E. Shane Relationship between Moderate to Severe Kidney Disease and Hip Fracture in the United States J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3223 - 3232. [Abstract] [Full Text] [PDF]

				H. Kaji, M. Yamauchi, K. Chihara, and T. Sugimoto The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism Eur. J. Endocrinol., September 1, 2005; 153(3): 373 - 378. [Abstract] [Full Text] [PDF]

				A. Sakamoto, M. Chen, T. Nakamura, T. Xie, G. Karsenty, and L. S. Weinstein Deficiency of the G-protein {alpha}-Subunit Gs{alpha} in Osteoblasts Leads to Differential Effects on Trabecular and Cortical Bone J. Biol. Chem., June 3, 2005; 280(22): 21369 - 21375. [Abstract] [Full Text] [PDF]

				Q. Chen, H. Kaji, M.-F. Iu, R. Nomura, H. Sowa, M. Yamauchi, T. Tsukamoto, T. Sugimoto, and K. Chihara Effects of an Excess and a Deficiency of Endogenous Parathyroid Hormone on Volumetric Bone Mineral Density and Bone Geometry Determined by Peripheral Quantitative Computed Tomography in Female Subjects J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4655 - 4658. [Abstract] [Full Text] [PDF]

				F. K. W. Chan, S.-C. Tiu, K.-L. Choi, C.-H. Choi, A. P. S. Kong, and C.-C. Shek Increased Bone Mineral Density in Patients with Chronic Hypoparathyroidism J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3155 - 3159. [Abstract] [Full Text] [PDF]

				M. R. Rubin, K. H. Lee, D. J. McMahon, and S. J. Silverberg Raloxifene Lowers Serum Calcium and Markers of Bone Turnover in Postmenopausal Women with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1174 - 1178. [Abstract] [Full Text] [PDF]

				C. R. Parker, P. J. Blackwell, K. J. Fairbairn, and D. J. Hosking Alendronate in the Treatment of Primary Hyperparathyroid-Related Osteoporosis: A 2-Year Study J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4482 - 4489. [Abstract] [Full Text] [PDF]

				M. R. Rubin and J. P. Bilezikian The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4033 - 4041. [Full Text] [PDF]

				P. Lips Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications Endocr. Rev., August 1, 2001; 22(4): 477 - 501. [Abstract] [Full Text] [PDF]

				G. Khastgir, J. Studd, N. Holland, J. Alaghband-Zadeh, S. Fox, and J. Chow Anabolic Effect of Estrogen Replacement on Bone in Postmenopausal Women with Osteoporosis: Histomorphometric Evidence in a Longitudinal Study J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 289 - 295. [Abstract] [Full Text]

				D. Nakaoka, T. Sugimoto, T. Kobayashi, T. Yamaguchi, A. Kobayashi, and K. Chihara Prediction of Bone Mass Change after Parathyroidectomy in Patients with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1901 - 1907. [Abstract] [Full Text]

				S. J. Silverberg, E. Shane, T. P. Jacobs, E. Siris, and J. P. Bilezikian A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery N. Engl. J. Med., October 21, 1999; 341(17): 1249 - 1255. [Abstract] [Full Text] [PDF]

				D. W. Dempster, M. Parisien, S. J. Silverberg, X.-G. Liang, M. Schnitzer, V. Shen, E. Shane, D. B. Kimmel, R. Recker, R. Lindsay, et al. On the Mechanism of Cancellous Bone Preservation in Postmenopausal Women with Mild Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1562 - 1566. [Abstract] [Full Text]

				Y. Duan, V. De Luca, and E. Seeman Parathyroid Hormone Deficiency and Excess: Similar Effects on Trabecular Bone But Differing Effects on Cortical Bone J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 718 - 722. [Abstract] [Full Text]